Évolution de la testostéronémie chez les patients traités par hormonothérapie pour un cancer prostatique-Reference-Cited by-同舟云学术

Évolution de la testostéronémie chez les patients traités par hormonothérapie pour un cancer prostatique

Published:2008-01 Issue:1 Volume:18 Page:2-8
ISSN:1166-7087
Container-title:Progrès en Urologie
language:fr
Short-container-title:Progrès en Urologie

Author:

Peyromaure M.,Rebillard X.,Ruffion A.,Salomon L.,Villers A.,Soulie M.

Publisher

Elsevier BV

Subject

Urology

Reference34 articles.

1. Adenocarcinoma of prostate: role of 17beta-estradiol and 5alpha-dihydrotestosterone binding proteins;Sidh;Urology,1979

2. Studies on prostate cancer; effect of castration, estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

3. Independent prognostic factors in patients with metastatic (stage D2) prostate cancer;Chodak;JAMA,1991

4. Clinical predictors of androgen-independent prostate cancer and survival in the prostate specific antigen era;Oefelein;Urology,2002

5. Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer;Sabbatini;J Clin Oncol,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parameter identification of a model for prostate cancer treated by intermittent therapy;Journal of Theoretical Biology;2019-01

2. Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment;Environmental Health;2015-02-11

3. Les nouvelles perspectives de prise en charge du cancer de la prostate;Progrès en Urologie;2010-07

4. Cancer de la prostate et hormonothérapie : indications thérapeutiques de première ligne;Progrès en Urologie;2010-02